Elbow dysplasia is heritable. That much has been established beyond debate for decades. But saying a condition is "genetic" tells breeders almost nothing actionable. The critical questions are: how heritable, through what mechanism, which genes are involved, and how can breeders use genetic information to make better decisions? The answers to these questions have evolved substantially over the past decade as genomic technologies have moved from research curiosity to practical breeding tools. Yet much of the breeding community still relies on a simplified understanding of ED genetics that was current in the 1990s. This article synthesizes the current evidence on elbow dysplasia heritability, the polygenic threshold model, genomic discoveries, and the practical application of estimated breeding values in selection programs.
Heritability: What the Numbers Mean
Heritability, expressed as h-squared, measures the proportion of phenotypic variation in a population attributable to genetic differences between individuals. For elbow dysplasia, published heritability estimates range from 0.10 to 0.45 depending on breed, population, and study methodology. This range has important implications for selection programs.
| Breed | Heritability Estimate (h2) | Study | Population |
|---|---|---|---|
| German Shepherd | 0.25-0.35 | Malm et al. (2008) | Swedish KC (n=24,600) |
| Labrador Retriever | 0.27-0.38 | Lewis et al. (2011) | UK BVA/KC (n=18,400) |
| Rottweiler | 0.30-0.45 | Maki et al. (2004) | Finnish KC (n=9,800) |
| Golden Retriever | 0.22-0.32 | Woolliams et al. (2011) | UK BVA/KC (n=12,300) |
| Bernese Mountain Dog | 0.15-0.28 | Janutta et al. (2006) | German KC (n=6,200) |
| Belgian Malinois | 0.20-0.30 | Lavrijsen et al. (2014) | Dutch population (n=4,100) |
Heritability estimates vary by statistical model and population structure. Ranges reflect different analytical approaches applied to the same or similar datasets.
A heritability of 0.30, roughly the average across breeds and studies, means that 30% of the variation in ED status between individuals within a population is attributable to additive genetic effects. The remaining 70% reflects environmental factors, gene-environment interactions, non-additive genetic effects, and random developmental variation. This moderate heritability explains a frustrating reality: breeding two clear-screened parents still produces affected offspring at rates of 5-15%, depending on the genetic background of the pedigree.
Why Heritability Is Not Destiny
A heritability of 0.30 does not mean a puppy has a 30% chance of inheriting ED. Heritability is a population statistic, not an individual prediction. It describes how much genetic selection can shift population-level prevalence over generations. With h2 of 0.30, aggressive phenotypic selection would be expected to reduce ED prevalence by approximately 2-4% per generation, consistent with what Scandinavian breeding programs have achieved over 20-30 years of mandatory screening.
The Polygenic Threshold Model
Elbow dysplasia does not follow simple Mendelian inheritance. There is no single "ED gene" that can be tested and eliminated. Instead, ED follows a polygenic threshold model: many genes, each with small individual effects, contribute to an underlying continuous liability. When the cumulative liability exceeds a threshold, the disease is expressed.
This model explains several otherwise puzzling observations about ED inheritance:
- Clear parents producing affected offspring: Both parents may carry subthreshold liability that combines in some offspring to exceed the disease threshold.
- Affected parents producing clear offspring: Some offspring inherit a favorable combination of alleles that keeps their liability below threshold, despite parental disease.
- Variable severity among affected littermates: Dogs above threshold can be mildly or severely affected depending on how far their liability exceeds it.
- Environmental modulation: Factors such as nutrition during growth, body weight, and exercise patterns shift the threshold rather than the genetic liability, explaining why environmental management reduces disease expression without changing genotype.
The Threshold Shift Concept
Environmental factors do not change a dog's genetic liability for ED. Rather, they shift the threshold at which disease is expressed. A puppy raised on controlled-calorie, appropriate-calcium large breed food may never cross the disease threshold despite carrying significant genetic liability. The same puppy raised on ad libitum high-calorie food with calcium supplementation might develop Grade 2 ED. The genetics are identical; the threshold position differs. This is why nutritional management matters even when genetics "look clean."
Component-Specific Genetics
Growing evidence suggests that the three classical elbow dysplasia components, fragmented coronoid process (FCP), osteochondritis dissecans (OCD), and ununited anconeal process (UAP), may have partially distinct genetic architectures. This has important implications for breeding programs that treat ED as a single condition.
| ED Component | Genetic Architecture | Key Findings |
|---|---|---|
| FCP | Highly polygenic; strong environmental interaction | Lavrijsen et al. (2014) identified QTLs on chromosomes 17 and 26 in Labradors; explains only 10-15% of variance |
| OCD | Polygenic with moderate-effect loci | Possible shared genetic factors with OCD at other joint locations; chromosome 3 locus identified in multiple breeds |
| UAP | May involve fewer genes with larger effects | Bartolome et al. (2015) identified a significant QTL on chromosome 12 in German Shepherds; higher heritability estimates than FCP |
The clinical relevance is this: selecting against overall ED grade may reduce all three components simultaneously, but the rate of progress will differ. UAP, with potentially larger-effect genes and higher heritability, may respond faster to selection pressure than FCP, where many small-effect genes make genetic progress slower. This partly explains why breed-specific prevalence data shows different component distributions across breeds, as selection pressures interact differently with each component's genetic architecture.
Genomic Tools: Where We Are in 2026
The promise of genomic testing for elbow dysplasia has been discussed for over a decade. Progress has been real but slower than initial optimism suggested. The current state of genomic tools for ED can be summarized honestly.
Genome-Wide Association Studies (GWAS)
Multiple GWAS have identified chromosomal regions associated with ED in various breeds. However, no study has identified a single locus explaining more than 15% of genetic variance. The typical finding is multiple loci, each explaining 2-5% of variance, consistent with the polygenic model. Importantly, many identified loci are breed-specific, meaning a QTL significant in Labrador Retrievers may not be relevant in Rottweilers.
SNP Panels and Genomic Prediction
Commercial SNP arrays (typically 100,000-200,000 markers) enable genomic estimated breeding values (gEBVs) that incorporate DNA information alongside pedigree and phenotype data. The Scandinavian kennel clubs and several breed-specific programs are piloting gEBV-based selection for ED.
What Genomic Tools Can Do Now
- Improve breeding value accuracy by 20-40% compared to pedigree alone
- Estimate genetic merit before phenotypic screening age
- Identify high-risk puppies for enhanced monitoring
- Detect cryptic relatedness between seemingly unrelated dogs
- Inform management of breeds with small effective population sizes
What Genomic Tools Cannot Do Yet
- Replace radiographic or CT-based screening for individual diagnosis
- Predict with certainty whether an individual will develop ED
- Identify all carrier animals in a breeding population
- Provide breed-transferable markers across all affected breeds
- Distinguish between FCP, OCD, and UAP genetic risk accurately
Beware of Oversold Commercial Tests
Several commercial laboratories offer "elbow dysplasia risk" panels based on limited SNP markers. These tests typically explain less than 15% of genetic variance for ED and should not be used as the sole basis for breeding decisions. A low-risk genomic result does not guarantee a sound dog, and a high-risk result does not guarantee disease. Genomic data is most valuable when combined with phenotypic screening and pedigree analysis, not as a standalone replacement.
Estimated Breeding Values: The Practical Tool
For most breeders, estimated breeding values (EBVs) represent the most immediately useful genetic tool available. EBVs estimate an individual's genetic merit for ED by incorporating information from the individual, its parents, siblings, offspring, and more distant relatives, weighted by their degree of relatedness.
How EBVs Work
A simplified example: Dog A is ED Grade 0 with three siblings, two Grade 0 and one Grade 2. Dog B is ED Grade 0 with three siblings, all Grade 0. Both dogs have identical phenotypes, but Dog B has a better EBV because its relatives provide additional evidence of favorable genetics. If Dog A's offspring data shows 18% affected versus Dog B's 6% affected, the EBV calculation adjusts further to reflect this progeny information.
EBV Impact: The Swedish Evidence
The Swedish Kennel Club has published EBVs for elbow dysplasia since 2000. Malm et al. (2008) documented the impact: breeding programs using EBV-based selection reduced German Shepherd ED prevalence by 8.2% over 15 years, compared to 2.1% reduction in programs using individual phenotype selection alone. This four-fold improvement in genetic progress validates the additional complexity of EBV calculation. The Finnish Kennel Club has reported similar results, with Labrador Retriever ED prevalence declining from 14.8% to 9.2% between 2003 and 2020 using EBV-guided selection.
EBV Availability by Country
| Country/Organization | EBV Status | Access |
|---|---|---|
| Sweden (SKK) | Published for all breeds with sufficient data | Free via SKK Avelsdata |
| Finland (FKC) | Published for major breeds | Free via Jalostustietjarjestelma |
| Norway (NKK) | Published for selected breeds | Via DogWeb |
| Netherlands (Raad van Beheer) | Calculated for selected breeds | Available to breeders on request |
| UK (BVA/KC) | In development; pilot programs underway | Not yet publicly available |
| USA (OFA) | Not calculated | Breeders must perform manual pedigree analysis |
| Germany (SV) | Zuchtwert calculated for German Shepherds | Via SV breed database |
Breeders in countries without formal EBV systems can approximate the approach by systematically collecting screening data from relatives and calculating affected rates across generations, as outlined in our guide to breeding decisions based on elbow scores. While less statistically rigorous than formal EBV calculation, this manual pedigree analysis still outperforms individual phenotype selection alone.
Gene-Environment Interaction
One of the most clinically significant aspects of ED genetics is the substantial gene-environment interaction. Dogs with moderate genetic liability may or may not develop clinical disease depending on environmental exposures during critical developmental windows. This interaction explains why identical twins (rare but documented in dogs) can have different ED outcomes when raised in different environments.
The major environmental modifiers with documented genetic interaction include:
- Growth rate: Genetically predisposed puppies raised on controlled-calorie diets show lower ED expression than fast-growing littermates. The genetic liability is identical; the environmental trigger differs.
- Body weight: Heavier dogs within a breed show higher ED prevalence, but this relationship is stronger in genetically predisposed individuals than in those with low genetic liability.
- Calcium intake: Excess calcium during growth exacerbates endochondral ossification defects in genetically susceptible puppies with minimal effect on resistant genotypes.
- Exercise during growth: High-impact exercise before growth plate closure may trigger ED expression in predisposed individuals, though the evidence is less definitive than for nutritional factors.
The practical implication for breeders is clear: genetic selection and environmental management are complementary strategies, not alternatives. A breeding program that selects rigorously for low ED genetics but provides no nutritional guidance to puppy buyers undermines its own genetic progress. Conversely, optimal environmental management without genetic selection merely masks underlying liability that will express in future generations raised under less controlled conditions. For breeds where both elbow and hip dysplasia are prevalent, coordinating genetic selection across both conditions prevents improving one trait at the expense of the other, a strategy well-documented in shepherd breed health programs.
The Future of ED Genetics
Several developments will likely transform ED genetic management within the next decade:
- Whole-genome sequencing: As costs continue falling, whole-genome data will replace SNP panels, capturing rare variants that current arrays miss.
- Multi-breed reference populations: Combining genomic data across breeds will identify shared ED risk loci and improve prediction accuracy for breeds with small screening populations.
- Epigenetic markers: Research into DNA methylation patterns associated with ED may reveal how environmental exposures during gestation and early life "program" gene expression, potentially enabling risk stratification at birth.
- Integrated selection indices: Future breeding programs will likely use composite indices that balance ED genetic merit against hip dysplasia risk, temperament, longevity, and breed-specific health priorities, preventing overemphasis on any single trait.
Related Database Resources
- Breeding Decisions - Translating genetic data into mating choices
- Breed Prevalence - How genetics shape population-level risk
- Screening Protocol - Phenotypic data collection for EBV calculation
- ED Overview - Pathophysiology underlying genetic predisposition
Conclusion
Elbow dysplasia genetics is complex, polygenic, and modulated by environmental factors, but it is not intractable. The tools available today, estimated breeding values, pedigree analysis, and emerging genomic panels, enable meaningfully faster genetic progress than individual phenotype selection alone. Breeders who invest in collecting comprehensive screening data from relatives, who access EBVs where available, and who combine genetic selection with evidence-based environmental management are making the most effective use of current knowledge. The perfect genomic test remains elusive, but waiting for perfection while ignoring available tools wastes generations of potential progress.